Orasis Pharmaceuticals For Profit
Orasis is a company that aims to reshape vision possibilities for eye care providers and their presbyopic patients. They plan to launch QLOSI in the first half of 2024. Presbyopia is a progressive condition that affects most people after the age of 40. Orasis provides information about presbyopia and its mechanism of action. Contact_info: info@orasis-pharma.com.
Connections from
Industry:
Longevity Medicine
Technology:
Intracellular communication
Estimated Revenue:
$1M to $10M
Investors Number:
7
Headquarters:
Herzliya, Tel Aviv, Israel
Employee Number:
11-50
Investor Type:
Late Stage Venture
Total Funding:
43000000
Founded Date:
2015-01-01
Last Funding Type:
Series C
Last Funding Date:
2020